{"timestamp": 1771603335.005137, "value": {"ticker": "ENVB", "company_name": "Enveric Biosciences, Inc.", "short_name": "Enveric Biosciences, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 2857140, "float_shares": 515461, "shares_outstanding": 1390335, "short_ratio": 1.24, "short_percent_of_float": 0.0559, "shares_short": 77515, "shares_short_prior": 62720, "insider_percent_held": 0.053150002, "institution_percent_held": 0.08523, "total_cash": 3757594, "total_debt": 0, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 0, "current_ratio": 4.598, "book_value": 6.668, "price_to_book": 0.30818835, "operating_cashflow": -7668229, "free_cashflow": -3897664, "price": 2.055, "52w_high": 54.0, "52w_low": 1.96, "avg_volume": 722470, "avg_volume_10d": 47430, "full_time_employees": 5, "audit_risk": 0, "overall_risk": 0}}